PRURITIS Clinical Trials

26 clinical trials for PRURITIS across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• AN EXPLORATORY PROOF OF CONCEPT STUDY TO ASSESS THE PHARMACOKINETICS/PHARMACODYNAMICS OF NEMOLIZUMAB (CD14152) IN ADULT PARTICIPANTS WITH CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO) — RECRUITING
• Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic — RECRUITING · PHASE2
• Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis — RECRUITING · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB FOR THE TREATMENT OF PRURITUS OF LICHEN SIMPLEX CHRONICUS (LSC) IN ADULTS — RECRUITING · PHASE3
• ¿MASTER PROTOCOL OF TWO RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, PARALLEL GROUP STUDIES TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO)¿ — RECRUITING
• LONG-TERM SAFETY AND TOLERABILITY STUDY OF LINERIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PARTICIPANTS WITH PRIMARY BILIARY CHOLANGITIS. — RECRUITING
• A 52-WEEK MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF REMIBRUTINIB IN ADULT PARTICIPANTS WITH SEVERE CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO) — NOT_YET_RECRUITING · PHASE3
• A 52-WEEK MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF REMIBRUTINIB IN ADULT PARTICIPANTS WITH SEVERE CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO) — NOT_YET_RECRUITING · PHASE3
• Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria — COMPLETED · PHASE2
• INCIDENCE OF PRURITUS USING INTRATHECAL FENTANYL VERSUS EPIDURAL FENTANYL TO INITIATE LABOUR ANALGESIA — NOT_YET_RECRUITING
• Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis — COMPLETED · PHASE2
• Incidence of Pruritus Using Intrathecal Fentanyl Versus Epidural Fentanyl to Initiate Labour Analgesia. — NOT_YET_RECRUITING · NA
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 12-WEEK STUDY TO EVALUATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF ORAL DIFELIKEFALIN IN SUBJECTS WITH ADVANCED CHRONIC KIDNEY DISEASE AND MODERATE-TO-SEVERE PRURITUS WITH A 24-WEEK OPEN-LABEL EXTENSION — COMPLETED
• DIALYSIS SYMPTOM CONTROL-PRURITUS OUTCOME TRIAL (DISCO-POT): A RANDOMIZED BLINDED PLACEBO CONTROLLED CROSSOVER TRIAL — COMPLETED
• Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.S — COMPLETED · NA
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL DIFELIKEFALIN (CR845) FOR MODERATE TO SEVERE PRURITUS IN ADULT SUBJECTS WITH NOTALGIA PARESTHETICA — COMPLETED
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL DIFELIKEFALIN (CR845) FOR MODERATE TO SEVERE PRURITUS IN ADULT SUBJECTS WITH ATOPIC DERMATITIS — COMPLETED
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BLU-5937 FOR THE TREATMENT OF CHRONIC PRURITUS IN ADULT SUBJECTS WITH ATOPIC DERMATITIS (BLUEPRINT) — COMPLETED
• Relieving Chronic Itch: Oral Medication — WITHDRAWN · PHASE2
• Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients — COMPLETED · PHASE4
• A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVENOUS CR845 IN HEMODIALYSIS PATIENTS WITH MODERATE-TO-SEVERE PRURITUS, WITH A 52 WEEK OPEN LABEL EXTENSION — COMPLETED
• AN EXPLORATORY, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF SNA-120 (PEGCANTRATINIB) OINTMENT FOR THE SYMPTOMATIC TREATMENT OF PERSISTENT PRURITUS AND PSORIASIS IN SUBJECTS BEING TREATED WITH CALCIPOTRIENE OINTMENT — COMPLETED · PHASE2
• A PHASE 1B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE ASCENDING DOSES OF KPL-716 — COMPLETED · PHASE1
• A RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF GSK2330672 ADMINISTRATION FOR THE TREATMENT OF PRURITUS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS. — COMPLETED
• A Study of Oral Ergocalciferol to Treat Pruritis in Hemodialysis Patients — COMPLETED · PHASE4
• Nalbuphine for the Treatment of Opioid Induced Pruritus in Children — COMPLETED · PHASE3

Refine this search